UNSPSC 51282702: Vancomycin

This classification denotes an antibiotic with the molecular formula C66H75Cl2N9O24, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Q205EH1VU, chemically known as (s(sub a))-(3s,6r,7r,22r,23s,26s,36r,38ar)-44-((2-o-(3-amino-2,3,6-trideoxy-3-c-methyl-alpha-l-lyxo-hexopyranosyl)-beta-d-glucopyranosyl)oxy)-3-(carbamoylmethyl)-10,19-dichloro-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-((2r)-4-methyl-2-(methylamino)valeramido)-2,5,24,38,39-pentaoxo-22h-8,11:18,21-dietheno-23,36-(iminomethano)-13,16:31,35- but generally known as vancomycin, which bears US NIH Compound Identifier 14969.

UNSPSC 51282702 Vancomycin, a Commodity code, nominally designates a single pharmaceutical product — the antibiotic vancomycin — but recent state and local procurement activity under this code shows little relevant solicitation activity aligned with the code's stated scope. The two opportunities tagged to this code in the recent record do not involve vancomycin procurement; instead, they cover other pharmaceutical products and drug-related services, suggesting either misclassification by the issuing bodies or database tagging inconsistency rather than active market demand for vancomycin specifically through state and local solicitations.

The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract on August 28, 2026, through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under Invitation for Bid process 26482DPHPREPDB53392, with a total contract value of $2,999,999.11 over 12 months plus two optional renewal years. Separately, Seminole County, Florida released an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2023. The code shows activity primarily in Illinois and Florida, but the absence of opportunities explicitly procuring vancomycin itself suggests this Commodity code may not be generating material state and local procurement volume at this time.